Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Weighted Average)
Others
Ratios

NewGenIvf (NIVF) Shares Outstanding (Weighted Average) (2022 - 2025)

Historic Shares Outstanding (Weighted Average) for NewGenIvf (NIVF) over the last 4 years, with Q3 2025 value amounting to $96.76.

  • NewGenIvf's Shares Outstanding (Weighted Average) changed N/A to $96.76 in Q3 2025 from the same period last year, while for Sep 2025 it was $96.76, marking a year-over-year change of. This contributed to the annual value of $358108.0 for FY2024, which is 106431.38% up from last year.
  • As of Q3 2025, NewGenIvf's Shares Outstanding (Weighted Average) stood at $96.76.
  • In the past 5 years, NewGenIvf's Shares Outstanding (Weighted Average) ranged from a high of $358108.0 in Q4 2024 and a low of $2.53 during Q2 2025
  • For the 4-year period, NewGenIvf's Shares Outstanding (Weighted Average) averaged around $83552.3, with its median value being $28797.0 (2022).
  • In the last 5 years, NewGenIvf's Shares Outstanding (Weighted Average) surged by 680.63% in 2023 and then soared by 106431.38% in 2024.
  • Quarter analysis of 4 years shows NewGenIvf's Shares Outstanding (Weighted Average) stood at $28797.0 in 2022, then rose by 6.81% to $30757.0 in 2023, then soared by 1064.31% to $358108.0 in 2024, then crashed by 99.97% to $96.76 in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $96.76 for Q3 2025, versus $2.53 for Q2 2025 and $358108.0 for Q4 2024.